SCHEMBL6808318

SCHEMBL6808318

COC(=O)C(Cc1c[nH]c(=O)nc1NC(=O)c1c(Cl)cccc1Cl)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.43
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
CTSL P07711 2/20 0.39
CTSS P25774 2/20 0.39
CTSK P43235 2/20 0.39
SCN9A Q15858 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TERT O14746 2/20 0.38
SCN10A Q9Y5Y9 1/20 0.38
KLK5 Q9Y337 1/20 0.37
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
ACE P12821 1/20 0.36
KLK7 P49862 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7538602 0.82 TACR1 (0.47) TACR1MAPTTP53CTSLCTSS
SCHEMBL7539039 0.82 ITGB2 (0.48) TACR1MAPTTP53CTSLCTSS
SCHEMBL6807751 0.82 CYP3A4 (0.40) ITGB1ITGA4
SCHEMBL6807827 0.81 TACR1 (0.49) TACR1MAPTTP53CTSLCTSS
SCHEMBL6808623 0.81 CYP3A4 (0.42) TACR1MAPTTP53SMN1; SMN2ITGB1
SCHEMBL6806803 0.81 ITGB1 (0.39) SMN1; SMN2ITGB1ITGA4ITGB2ICAM1
SCHEMBL6804920 0.81 TACR1 (0.39) TACR1MAPTTP53SMN1; SMN2ITGB1
SCHEMBL6806499 0.80 GAA (0.35) MAPTTP53SMN1; SMN2ITGB1ITGA4
Trifluoroacetic Acid SCHEMBL6809034 0.80 ITGB1 (0.40) ITGB1ITGA4
SCHEMBL7542020 0.79 ITGB2 (0.53) ITGB1ITGA4ITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039040-A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient TORAY INDUSTRIES, INC. (JP) 2004-02-26 US disclosed
EP-1323709-A1 UREA DERIVATIVE AND ADHESIVE-MOLECULE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2003-07-02 EP disclosed
EP-1209147-A1 CARBOXYLIC ACID DERIVATIVES AND ADHESION MOLECULE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2002-05-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039040-A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient ICAM1, VCAM1, EPCAM TACR1 2733/4885MAPT 259/4885TP53 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.